Siga Technologies (SIGA) Interest Expenses (2011 - 2025)
Siga Technologies (SIGA) posted Interest Expenses of $200000.0 for Q3 2025, little changed on a QoQ basis from $200000.0 in Q2 2025, and down 87.87% year-over-year from $1.6 million in Q3 2024.
Siga Technologies (SIGA) Interest Expenses (2011 - 2025) Analysis & Trends
Siga Technologies' Interest Expenses history runs 15 years deep, the most recent figure standing at $200000.0 for Q3 2025.
- Quarterly Interest Expenses fell 87.87% year-over-year to $200000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $600000.0 (down 25.0% YoY) and the FY2024 annual result came in at $556.6 million, up 3801.34% from the prior year.
- Interest Expenses was $200000.0 for Q3 2025 at Siga Technologies, roughly flat from $200000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $3.2 million in Q2 2021 and bottomed at -$400000.0 in Q4 2021.
- A 5-year average of $1.1 million and a median of $200000.0 in 2023 frame the typical range for Interest Expenses.
- Peak annual rise in Interest Expenses reached 701.01% in 2021, while the deepest fall reached 115.29% in 2021.
- Siga Technologies' Interest Expenses stood at -$400000.0 in 2021, then surged by 125.0% to $100000.0 in 2022, then jumped by 100.0% to $200000.0 in 2023, then changed by 0.0% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025.
- Business Quant data shows SIGA's Interest Expenses at $200000.0 in Q3 2025, $200000.0 in Q2 2025, and $200000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Jun 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |